Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

ASTM Insider Trading

Vericel Corp | Biological Products, (No Diagnostic Substances)

Comprehensive Trading Performance Summary

The investment history of corporate insiders at Vericel Corp provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Biological Products, (No Diagnostic Substances) sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2014-09-18 00:16 2014-09-16 Orlando Daniel Officer - Chief Operating Officer BUY $2.55 9,804 $25,000 9,804 +100.0%
2014-09-18 00:16 2014-09-16 Colangelo Dominick Director, Officer - President and CEO BUY $2.55 20,000 $51,000 20,000 +100.0%
2014-09-18 00:17 2014-09-16 MICHEL GERARD J Officer - CFO and VP, Corp. Development BUY $2.55 20,000 $51,000 20,000 +100.0%
2012-01-07 01:49 2012-01-04 Durbin Scott Officer - CFO SELL $1.80 40,000 $72,000 0 -100.0%
2011-08-13 00:21 2011-08-10 Durbin Scott Officer - CFO BUY $2.24 10,850 $24,253 40,850 +36.2%
2011-08-12 23:28 2011-08-11 CRESSWELL RONALD M Director BUY $2.22 20,000 $44,400 40,000 +100.0%
2011-08-09 20:36 2011-08-08 MAYLEBEN TIMOTHY M Director, Officer - President and CEO BUY $2.11 10,000 $21,100 133,000 +8.1%
2011-08-08 23:47 2011-08-05 MAYLEBEN TIMOTHY M Director, Officer - President and CEO BUY $2.36 20,000 $47,200 123,000 +19.4%
2011-03-28 17:29 2011-03-24 CRESSWELL RONALD M Director BUY $2.19 20,000 $43,800 20,000 +100.0%
2011-03-08 23:47 2011-03-04 Durbin Scott Officer - Chief Financial Officer BUY $2.17 13,537 $29,375 30,000 +82.2%
2011-03-05 00:49 2011-03-02 MAYLEBEN TIMOTHY M Director, Officer - CEO and President BUY $2.12 21,382 $45,364 103,000 +26.2%
2010-11-30 02:05 2010-11-24 MAYLEBEN TIMOTHY M Director, Officer - CEO & President BUY $2.20 12,000 $26,340 81,618 +17.2%
2010-08-31 22:52 2010-08-30 MAYLEBEN TIMOTHY M Director, Officer - CEO and President BUY $1.45 17,200 $24,940 69,618 +32.8%
2010-08-27 22:20 2010-08-26 Durbin Scott Officer - CFO BUY $1.45 16,463 $23,842 16,463 +100.0%
2010-05-25 23:58 2010-05-21 MAYLEBEN TIMOTHY M Director, Officer - CEO, President, CFO & Director BUY $1.42 17,600 $24,992 52,418 +50.5%
2010-03-13 00:12 2010-03-10 DUNBAR GEORGE W JR Director BUY $1.56 9,000 $14,013 12,750 +240.0%
2010-03-10 01:09 2010-03-05 MAYLEBEN TIMOTHY M Director, Officer - CEO, President, CFO & Director BUY $1.46 33,956 $49,606 34,818 +3,939.2%
2007-11-13 17:25 2007-11-12 Brennan Gerald JR Officer - VP Admin. and Finance, CFO BUY $0.94 20,000 $18,800 30,000 +200.0%
2007-11-13 17:11 2007-11-12 SIMS NELSON M Director BUY $0.90 10,000 $9,000 10,000 +100.0%
2007-11-13 19:15 2007-11-12 DUNBAR GEORGE W JR Director, Officer - President & CEO BUY $0.90 20,000 $18,000 30,000 +200.0%
2007-09-17 20:03 2007-09-14 SUDOVAR STEPHEN Director BUY $1.12 10,000 $11,200 26,900 +59.2%
2007-05-15 18:58 2007-05-11 DUNBAR GEORGE W JR Director, Officer - President & CEO BUY $1.45 10,000 $14,492 10,000 +100.0%
2006-06-08 21:20 2006-06-06 ARMSTRONG R DOUGLAS PHD Officer - Chairman and CEO BUY $1.26 8,000 $10,080 573,763 +1.4%
2006-05-22 18:49 2006-05-18 SUDOVAR STEPHEN Director BUY $1.37 10,000 $13,700 16,900 +144.9%
2006-05-16 00:06 2006-05-12 Hock Janet Mary Officer - VP Global Research & CSO OPT+S $1.36 37,139 $50,442 37,136 0.0%
2006-02-16 20:52 2006-02-16 Brennan Gerald JR Officer - VP Admin. & Finance, CFO BUY $1.75 10,000 $17,500 10,000 +100.0%
2006-02-14 21:35 2006-02-13 ARMSTRONG R DOUGLAS PHD Officer - CEO and Chairman of the Board BUY $1.67 3,000 $5,010 565,763 +0.5%
2005-12-22 02:21 2005-12-20 FINGERLE LINDA M Other SELL $2.32 21,000 $48,720 6,927 -75.2%
SHOW ENTRIES

How to Interpret $ASTM Trades

Not every insider transaction in Vericel Corp is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $ASTM shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for ASTM

Insider activity data for Vericel Corp is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $ASTM, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.